Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBC
(MedPage Today) -- More than 40% of patients with muscle-invasive bladder cancer (MIBC) avoided immediate cystectomy after achieving a clinical complete response (cCR) with a chemoimmunotherapy combination, a prospective study showed.
Overall...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study